wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q34142714-1A3A282C-1B6F-4E05-B6CC-D8BA4B9DC62D
Q34142714-1A3A282C-1B6F-4E05-B6CC-D8BA4B9DC62D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34142714-1A3A282C-1B6F-4E05-B6CC-D8BA4B9DC62D
Have we overestimated the benefit of human(ized) antibodies?
P2860
Q34142714-1A3A282C-1B6F-4E05-B6CC-D8BA4B9DC62D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34142714-1A3A282C-1B6F-4E05-B6CC-D8BA4B9DC62D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6639844cff6c2f9a847f1a42d932d788975be7ae
P2860
Phase II trial of yttrium-90-DOTA-biotin pretargeted by NR-LU-10 antibody/streptavidin in patients with metastatic colon cancer.